Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Recruiting
N/A
Interventional Study
Gynecologic Cancer
Hereditary Cancer Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 150 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 8 years of age or older.
* Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
* Access to a telephone with texting capacity.
* Has not had prior genetic testing for hereditary cancer syndromes.
Exclusion Criteria:
* Under 18 years …
Contacts